---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-020295"
form_type: "8-K"
ticker: "DARE"
cik: "0001401914"
company_name: "Dare Bioscience, Inc."
filed_at: "2025-07-21T23:59:59+00:00"
generated_at: "2026-05-18T04:59:01.384376+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Dare Bioscience raises $16.5M, believes it regains Nasdaq equity compliance

## Summary
- Raised approx. $16.5M gross from ATM and equity line sales since Mar 31, 2025.
- Believes stockholders' equity now exceeds $2.5M Nasdaq minimum for continued listing.
- Will notify Nasdaq; no guarantee of regaining compliance.
- Shares outstanding will be ~12.6M after the sales.

## SEC filing metadata
- accession: 0001641172-25-020295
- form_type: 8-K
- ticker: DARE
- cik: 0001401914
- company_name: Dare Bioscience, Inc.
- filed_at: 2025-07-21T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401914/000164117225020295/0001641172-25-020295-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401914/000164117225020295/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-020295
- JSON: https://secwatch.observer/filing/0001641172-25-020295.json
- Plain text: https://secwatch.observer/filing/0001641172-25-020295.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.